Osteopontin: The Molecular Bridge between Fat and Cardiac–Renal Disorders
Open Access
- 4 August 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (15), 5568
- https://doi.org/10.3390/ijms21155568
Abstract
Osteopontin (OPN) is a multifaceted matricellular protein, with well-recognized roles in both the physiological and pathological processes in the body. OPN is expressed in the main organs and cell types, in which it induces different biological actions. During physiological conditioning, OPN acts as both an intracellular protein and soluble excreted cytokine, regulating tissue remodeling and immune-infiltrate in adipose tissue the heart and the kidney. In contrast, the increased expression of OPN has been correlated with the severity of the cardiovascular and renal outcomes associated with obesity. Indeed, OPN expression is at the “cross roads” of visceral fat extension, cardiovascular diseases (CVDs) and renal disorders, in which OPN orchestrates the molecular interactions, leading to chronic low-grade inflammation. The common factor associated with OPN overexpression in adipose, cardiac and renal tissues seems attributable to the concomitant increase in visceral fat size and the increase in infiltrated OPN+ macrophages. This review underlines the current knowledge on the molecular interactions between obesity and the cardiac–renal disorders ruled by OPN.This publication has 90 references indexed in Scilit:
- The multiple functions and mechanisms of osteopontinClinical Biochemistry, 2018
- Embracing the complexity of matricellular proteins: the functional and clinical significance of splice variationBioMolecular Concepts, 2016
- Revisiting the matricellular conceptMatrix Biology, 2014
- Matricellular proteins and biomaterialsMatrix Biology, 2014
- Human osteopontin splicing isoforms: Known roles, potential clinical applications and activated signaling pathwaysCancer Letters, 2013
- Regulation of the pro-inflammatory cytokine osteopontin by GIP in adipocytes – A role for the transcription factor NFAT and phosphodiesterase 3BBiochemical and Biophysical Research Communications, 2012
- Matricellular Proteins in Cardiac Adaptation and DiseasePhysiological Reviews, 2012
- Control of osteopontin signaling and function by post‐translational phosphorylation and protein foldingJournal of Cellular Biochemistry, 2007
- Osteopontin—a molecule for all seasonsQJM: An International Journal of Medicine, 2002
- Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) ImmunityScience, 2000